Posted on

will cbd oil test positive

Some CBD products may yield cannabis-positive urine drug tests

In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.

The U.S. government defines hemp as any crop of cannabis containing 0.3% THC or less in dry weight. THC (delta-9-tetrahydrocannabinol) is the substance in cannabis that confers a “high” and produces the subjective and cognitive effects that are typically synonymous with cannabis. The 2018 U.S. Farm Bill legalized the production and sale of hemp, and now as a result, consumer hemp products, such as oils, vaping cartridges and hemp flowers for smoking can be legally purchased in specialty stores, general retail stores and through websites across the U.S.

Hemp is now increasingly finding use in medicine and wellness markets, particularly for its component CBD, short for cannabidiol, which is one of the more than 100 cannabinoids found in the cannabis plant. According to New York-based investment bank Cowen & Co., the market for CBD last year ranged from $600 million and $2 billion in sales. Despite the size of this booming industry, it remains largely unregulated.

In a paper published Nov. 4 in the Journal of Analytical Toxicology, the researchers report that two out of six study participants tested positive after vaping cannabis that contained 0.39% THC using urine testing methods that are consistent with testing frequently performed for employment-related or criminal justice-related urine drug testing programs. Though the cannabis used in this study does not currently meet the federal definition of hemp, the THC concentration of 0.39% exceeds federal regulation by just 0.09%.

“People who use legal hemp products for medical intent rarely just use them once as we did in this study, and prior studies show that THC and its metabolites may accumulate with repeated use,” says postdoctoral fellow Tory Spindle, Ph.D., a researcher in the Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center. “What this means is that people need to be wary of single-dose or cumulative THC exposure and be aware that these now legal products may cause an unexpected positive result on a drug test.”

“Because the market for CBD products is so new and the popularity of use is growing so quickly, we want the public to be aware that a positive drug test is possible,” says Ryan Vandrey, Ph.D., associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. Vandrey and his collaborators at the University of Pennsylvania previously showed in a JAMA study that 21% of CBD/hemp products sold on the Internet contained THC, even though it wasn’t listed on the product labels. “I have a hard time finding anyone who hasn’t used a CBD product at least once, but most are completely unaware of the possibility of THC exposure or a positive drug test as a result of using these newly legalized products,” says Vandrey.

trials demonstrated CBD to be an effective treatment for two rare forms of pediatric epilepsy, however, there is currently insufficient evidence to support use for any other health condition according to the U.S. Food and Drug Administration. Despite this, CBD product suppliers and consumers claim benefits of CBD for a wide range of purposes, including everything from anxiety to insomnia to general wellness. CBD products can be swallowed in the form of an oil/tincture, eaten in a food product (e.g., gummy bears), inhaled using “vape pens” similar to electronic cigarettes, or applied topically to the skin in a cream, patch, balm or gel.

For the current study, the researchers recruited three women and three men with an average age of 31 years old. One participant self-reported as African American and the rest as white.

The batch of cannabis used in this particular study contained 10.5% CBD and 0.39% THC, a 27 to 1 ratio of CBD to THC that is similar to what is often found in legal hemp/CBD products. In the study, research volunteers vaporized a little less than 1 gram of cannabis, which contained a total dose of 100 milligrams of CBD and 3.7 milligrams of THC. To vape the cannabis, heated cannabis vapor was collected into a balloon that was then inhaled by the participant.

In addition to vaping the high CBD/low THC cannabis, study volunteers also were given pure CBD in a capsule, vaporized pure CBD and placebo (a mock CBD pill and vaporized cannabis in which CBD and THC had been removed) in three other dosing sessions, one week apart from each other. In all active drug conditions (excluding placebo), the CBD dose delivered was 100 milligrams per session.

The drug testing cut-off used to determine a “positive” result in this study was a “screening” concentration of at least 50 nanograms per milliliter of THCCOOH, a metabolite used to indicate whether someone has used cannabis, in the urine sample using an on-site “dipstick” test. A positive on that test was then “confirmed” at a 15 nanograms per milliliter cut-off of THCCOOH using a more sensitive test method.

Two of the six participants who vaped the low-THC/high-CBD cannabis tested positive for THCCOOH.

No positive urine drug test results were observed in the other test sessions (pure CBD capsules, pure CBD vape or placebo).

“These results suggest that pure CBD, used once by itself, will not cause a positive drug test,” says Vandrey. Adding to this, Spindle points out that it “does not take much THC exposure to trigger a positive test for some people.” There may be variation from person to person in drug metabolism and puffing behaviors such as inhalation depth, which might contribute to the breakdown or buildup of cannabinoids in the body, the researchers say.

The team says they plan to repeat their studies using products that fall within the current federal hemp regulations with respect to THC content, and additionally study the impact of repeated CBD/hemp exposure on drug testing outcomes.

Other authors on the study were Edward Cone and George Bigelow of Johns Hopkins, David Kuntz of Clinical Reference Laboratory, John Mitchell of RTI International and Ronald Flegel of the Substance Abuse and Mental Health Services Administration (SAMHSA).

This research was supported by SAMHSA and the National Institute on Drug Abuse (T32DA07209).

COI: Vandrey has been a paid consultant for or received honoraria from Zynerba Pharmaceuticals, FSD Pharma and Canopy Health Innovations Inc.

Hemp is now increasingly finding use in medicine and wellness markets, particularly for its component CBD, short for cannabidiol, which is one of the more than 100 cannabinoids found in the cannabis plant. According to New York-based investment bank Cowen & Co., the market for CBD last year ranged from $600 million and $2 billion in sales. Despite the size of this booming industry, it remains largely unregulated.

In a paper published Nov. 4 in the Journal of Analytical Toxicology, the researchers report that two out of six study participants tested positive after vaping cannabis that contained 0.39% THC using urine testing methods that are consistent with testing frequently performed for employment-related or criminal justice-related urine drug testing programs. Though the cannabis used in this study does not currently meet the federal definition of hemp, the THC concentration of 0.39% exceeds federal regulation by just 0.09%.

“People who use legal hemp products for medical intent rarely just use them once as we did in this study, and prior studies show that THC and its metabolites may accumulate with repeated use,” says postdoctoral fellow Tory Spindle, Ph.D., a researcher in the Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center. “What this means is that people need to be wary of single-dose or cumulative THC exposure and be aware that these now legal products may cause an unexpected positive result on a drug test.”

“Because the market for CBD products is so new and the popularity of use is growing so quickly, we want the public to be aware that a positive drug test is possible,” says Ryan Vandrey, Ph.D., associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. Vandrey and his collaborators at the University of Pennsylvania previously showed in a JAMA study that 21% of CBD/hemp products sold on the Internet contained THC, even though it wasn’t listed on the product labels. “I have a hard time finding anyone who hasn’t used a CBD product at least once, but most are completely unaware of the possibility of THC exposure or a positive drug test as a result of using these newly legalized products,” says Vandrey.

Trials demonstrated CBD to be an effective treatment for two rare forms of pediatric epilepsy, however, there is currently insufficient evidence to support use for any other health condition according to the U.S. Food and Drug Administration. Despite this, CBD product suppliers and consumers claim benefits of CBD for a wide range of purposes, including everything from anxiety to insomnia to general wellness. CBD products can be swallowed in the form of an oil/tincture, eaten in a food product (e.g., gummy bears), inhaled using “vape pens” similar to electronic cigarettes, or applied topically to the skin in a cream, patch, balm or gel.

For the current study, the researchers recruited three women and three men with an average age of 31 years old. One participant self-reported as African American and the rest as white.

The batch of cannabis used in this particular study contained 10.5% CBD and 0.39% THC, a 27 to 1 ratio of CBD to THC that is similar to what is often found in legal hemp/CBD products. In the study, research volunteers vaporized a little less than 1 gram of cannabis, which contained a total dose of 100 milligrams of CBD and 3.7 milligrams of THC. To vape the cannabis, heated cannabis vapor was collected into a balloon that was then inhaled by the participant.

In addition to vaping the high CBD/low THC cannabis, study volunteers also were given pure CBD in a capsule, vaporized pure CBD and placebo (a mock CBD pill and vaporized cannabis in which CBD and THC had been removed) in three other dosing sessions, one week apart from each other. In all active drug conditions (excluding placebo), the CBD dose delivered was 100 milligrams per session.

The drug testing cut-off used to determine a “positive” result in this study was a “screening” concentration of at least 50 nanograms per milliliter of THCCOOH, a metabolite used to indicate whether someone has used cannabis, in the urine sample using an on-site “dipstick” test. A positive on that test was then “confirmed” at a 15 nanograms per milliliter cut-off of THCCOOH using a more sensitive test method.

Two of the six participants who vaped the low-THC/high-CBD cannabis tested positive for THCCOOH.

No positive urine drug test results were observed in the other test sessions (pure CBD capsules, pure CBD vape or placebo).

“These results suggest that pure CBD, used once by itself, will not cause a positive drug test,” says Vandrey. Adding to this, Spindle points out that it “does not take much THC exposure to trigger a positive test for some people.” There may be variation from person to person in drug metabolism and puffing behaviors such as inhalation depth, which might contribute to the breakdown or buildup of cannabinoids in the body, the researchers say.

The team says they plan to repeat their studies using products that fall within the current federal hemp regulations with respect to THC content, and additionally study the impact of repeated CBD/hemp exposure on drug testing outcomes.

Other authors on the study were Edward Cone and George Bigelow of Johns Hopkins, David Kuntz of Clinical Reference Laboratory, John Mitchell of RTI International and Ronald Flegel of the Substance Abuse and Mental Health Services Administration (SAMHSA).

This research was supported by SAMHSA and the National Institute on Drug Abuse (T32DA07209).

A small study concludes that caution is warranted for users of ‘high CBD, low THC’ cannabis products.

Will CBD Oil Result in a Positive Drug Test?

Arno Kroner, DAOM, LAc, is a board-certified acupuncturist, herbalist, and integrative medicine doctor practicing in Santa Monica, California.

CBD (cannabidiol) oil is a popular product for everything from pain control to anxiety to promoting sleep. However, with the rise of CBD comes the concern about failing a drug test due to detection of CBD oil. News stories are emerging across the country involving famous sports players, employees of companies, and others who have gotten positive drug screening results for the presence of THC—the psychoactive component of marijuana   —even though CBD oil is said to be THC-free.

What are the odds that CBD oil users will test positive when subjected to illicit drug screenings, and what can be done to prevent it?

How to Avoid a Positive CBD Drug Test

Does CBD Oil Contain THC?

When a drug test is performed, the active chemical in marijuana that gets detected in a positive screening is THC. However, most people are under the impression that CBD oil is THC-free.

As it turns out, depending on the source of the cannabis that is used to produce the CBD oil, some products do contain traces of THC (including low-quality isolates and many full-spectrum tinctures).

Breakdown of Cannabis

Cannabis is the umbrella term describing hemp and marijuana plants—two different varieties of the cannabis genus. Both marijuana and hemp can be described as cannabis plants; however, it is important to note that they are still two separate plants.

CBD is one of many active chemical compounds in the cannabis plant. One reason it’s gaining momentum in popularity is because it is said to lack the component of the plant that causes a person to get high, which is called THC (tetrahydrocannabinol).  

The primary difference between hemp and marijuana is that hemp is nearly void of THC. In fact, a cannabis strain must contain less than .3 percent THC to be classified as hemp. This is the reason hemp can be legally sold as various products.

Most CBD products are made from hemp, not marijuana.

There are many distinctions between marijuana and hemp that relate to CBD oil. Marijuana contains both THC (the psychoactive component) and CBD, whereas hemp contains CBD and only trace amounts of THC. Hemp contains many cannabinoids—CBD is only one example.

There are several techniques for extracting CBD oil from the cannabis plant. The extraction method determines whether the active CBD compound gets processed as a “full spectrum oil” or an “isolate.” A CBD isolate is a pure compound with no other active compounds or cannabinoids at all. A full spectrum oil contains other active plant compounds in addition to the CBD such as CBN (cannabinol) and cannabis terpenes (the part of the plant that gives the plant its aroma), and more.

Study of CBD Oil

While some CBD oils claim to be isolates, they may be full spectrum oils and actually contain more cannabinoids (such as THC) than they claim.

In a study conducted by researchers from the Lautenberg Center, researchers discovered that CBD was more effective for treating inflammation and pain when used with other cannabis plant compounds derived from a full spectrum product over a CBD isolate product alone. This is one reason that full spectrum products (those containing THC) are popular.

However, the distinction between full spectrum oils and isolates make all the difference if you are being tested for drug use.

Reasons for Failing a CBD Drug Test

There are several common reasons a person fails a CBD drug test.

1. Using Product With THC

The most common reason for a failed CBD drug test is that a person is using a CBD oil product that contains THC. Sometimes, this may be because a person purchases a low-quality product that does contain a small amount of THC—most manufacturers will claim their products do not contain THC, but this is not always the case.

2. Cross Contamination of THC

Very small amounts of THC present in the material that CBD is extracted from can get into the CBD oil in high enough amounts to result in a positive drug test. This scenario may be more apt to occur when CBD oil is purchased from cannabis dispensaries in places where cannabis is legal, as opposed to an online retailer.

3. Mislabeling of Products

CBD oil extracted from hemp is not supposed to have any more than .3 percent of THC. However, it’s not uncommon for sellers to mislabel their products as THC-free hemp when in reality, it’s a low-quality oil extracted from marijuana, which does contain THC.

In fact, one study discovered that almost 70 percent of the CBD products sold online were not labeled properly, “causing potential serious harm to its consumers.” The reason for this widespread mislabeling is that CBD products are not strictly regulated by the FDA.

4. Secondhand Exposure to THC

Inadvertent exposure to marijuana (via secondhand smoke) is unlikely to be enough for a person to get a positive drug test result, but it is possible. Being in a room with heavy pot smokers for several hours may cause the inhalation of enough THC containing smoke to result in a positive test.  

A more likely secondhand exposure scenario is a positive marijuana hair test, resulting from direct contact with marijuana paraphernalia or from another person having THC on their hands.

For instance, if someone who had direct contact with marijuana then touched your hair, you could feasibly receive a false positive on a drug screening that tests your hair.

5. CBD Oil Breaks Down in The Digestive System

Some sources report that in rare cases, false positive test results have come from CBD oil that breaks down into very small amounts of THC in the stomach. Other studies, however, have refuted this.  

The conclusion is that it’s still theoretically possible for traces of THC metabolites to be present in the stomach acid in the instance where “less-purified CBD productions” are ingested.

How to Avoid a Positive CBD Drug Test

If you take CBD oil, there are measures you can take to try to prevent failing a drug test.

  • Do thorough research to ensure the CBD product you’re using is pure and that the company is legitimate.
  • Ensure that the CBD oil is an isolate product extracted from a viable industrial hemp supply, and is not a low-quality tincture.
  • Ask questions about product processing techniques and the possibility of cross-contamination.
  • Avoid secondhand exposure to marijuana use via pot smoking or hair contact from THC users.

A Word From Verywell

In theory, getting a false positive on a drug test from CBD oil should be relatively impossible from pure CBD oil containing less than .3 percent THC. However, because CBD oil is not very well regulated, there is no guarantee that a product contains pure CBD oil, or that its concentration is at a safe or effective level.   It is best to use utmost caution and do your research when purchasing a quality CBD oil product to ensure its purity, especially if you need to undergo drug screenings.

Cases of CBD oil users failing drug tests are on the rise. Learn more about why this happens and how to avoid it.